glp 1 approved for osa glp-1 sleep apnea Did You Know? The FDA has approved GLP-1 treatments for moderate to severe obstructive sleep apnea (OSA) in adults with obesity. This breakthrough provides a new Dr. Anne Marie Morse Explains

[DOI] [PubMed] [Google Scholar] 56.Payne S, et al

Additionally, those who regularly consume yerba mate often report that it enhances alertness like coffee but without the jittery side effects

Type 2 diabetes mellitus

As seen for the GIP receptor knockout mice, VLP-GIP efficiently reduced body weight gain in animals on a high-fat diet (69), supporting that the GIP receptor plays a role in developing obesity

These effects may be particularly relevant in patients with comorbid obesity and obstructive sleep apnea (OSA), conditions frequently co-occurring with SUDs such as alcoholism and opioid dependence [36,37]

Should these patients go on to develop PDR, they need to be referred to ophthalmology for anti-VEGF or PRP